Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Immunic Inc
IMUX | US
0.88
USD-0.04
-4.16%
IMUX | US
Loading StockChartView...
About Immunic Inc
Sector
92847R104
Industry
92847R104
Earnings date
30/06/2024
As of date
24/04/2026
Close
0.88
Open
0.90
High
0.92
Low
0.87
Immunic Inc. a clinical-stage biopharmaceutical company develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838 which is in Phase 3 clinical for treatment of multiple sclerosis including relapsing multiple sclerosis and other chronic inflammatory and autoimmune diseases as well as to treat coronavirus disease. The company is also developing IMU-935 an inverse agonist of retinoic acid receptor-related orphan nuclear receptor gamma truncated; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases such as celiac disease inflammatory bowel disease irritable bowel syndrome with diarrhea and other intestinal barrier function diseases. Immunic Inc. is headquartered in New York New York.
View LessIMUX | US
Risk
91.1
Sharpe
-0.28
Luna's Score
39/100
Recommendation
Sell
Luna says (IMUX | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
71.2%1 month
91.1%3 months
105.0%6 months
89.7%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
2.25
Debt to equity
0.02
Debt to assets
0.01
Ent. to EBITDA
0.21
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-93.53M
MarketCap
79.28M
MarketCap(USD)
79.28M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-143.47
Short ratio
4.77
Short perc.
3.01
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.49
Range1M
0.50
Range3M
0.94
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.41
Price X volume
3.41M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.21 | - | - |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | - | - |
| Price to Book | 2.25 | - | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 105.03 | - | - |
| Debt to Equity | 0.02 | - | - |
| Debt to Assets | 0.01 | - | - |
| Market Cap | 79.28M | - | - |
